Tanaka T, Nagai R, Tomoike H, Takata S, Yano K, Yabuta K, Haneda N, Nakano O, Shibata A, Sawayama T, Kasai H, Yazaki Y, Nakamura Y
Laboratory of Molecular Medicine, University of Tokyo, Japan.
Circulation. 1997 Feb 4;95(3):565-7. doi: 10.1161/01.cir.95.3.565.
Familial long-QT syndrome (LQTS) is characterized by prolonged ventricular repolarization. Clinical symptoms include recurrent syncopal attacks, and sudden death may occur due to ventricular tachyarrhythmias. Three genes responsible for this syndrome (KVLQT1, HERG, and SCN5A) have been identified so far. We investigated mutations of these genes in LQTS families.
Thirty-two Japanese families with LQTS were brought together for screening for mutations. Genomic DNA from each proband was examined by the polymerase chain reaction-single-strand conformation polymorphism technique followed by direct DNA sequencing. In four of the families, comprising 16 patients, mutations were identified in KVLQT1; five other families (9 patients) segregated mutant alleles of HERG. All 25 of these patients carried the specific mutations present in their respective families, and none of 80 normal individuals carried these alleles. Mutations were confirmed by endonuclease digestion or hybridization of mutant allele-specific oligonucleotides. No mutation in SCN5A was found in any family.
We identified nine different mutations among 32 families with LQTS. Eight of these were novel and account for 25% of all types of mutations reported to date. Such a variety of mutations makes it difficult to screen high-risk groups using simple methods such as endonuclease digestion or mutant allele-specific amplification.
家族性长QT综合征(LQTS)的特征是心室复极延长。临床症状包括反复发作的晕厥,且可能因室性快速心律失常而发生猝死。迄今为止,已确定了三个与该综合征相关的基因(KVLQT1、HERG和SCN5A)。我们对LQTS家族中的这些基因进行了突变研究。
将32个日本LQTS家族集中起来进行突变筛查。通过聚合酶链反应-单链构象多态性技术对每个先证者的基因组DNA进行检测,随后进行直接DNA测序。在其中4个家族(共16例患者)中,在KVLQT1基因中发现了突变;另外5个家族(9例患者)分离出了HERG基因的突变等位基因。所有这25例患者均携带各自家族中存在的特定突变,而80名正常个体中均未携带这些等位基因。通过核酸内切酶消化或突变等位基因特异性寡核苷酸杂交对突变进行了确认。在任何家族中均未发现SCN5A基因的突变。
我们在32个LQTS家族中鉴定出了9种不同的突变。其中8种是新发现的,占迄今为止报道的所有突变类型的25%。如此多样的突变使得使用核酸内切酶消化或突变等位基因特异性扩增等简单方法筛查高危人群变得困难。